Aquarius Surgical Technologies (AQQRF) Ratios

7 Followers

Aquarius Surgical Technologies Ratios

AQQRF's free cash flow for Q4 2026 was C$0.58. For the 2026 fiscal year, AQQRF's free cash flow was decreased by C$ and operating cash flow was C$-1.09. See a summary of the company’s cash flow.

Ratios	TTM	Jun 26	Jun 25	Jun 23	Mar 21
Liquidity Ratios
Current Ratio	―	0.06	0.06	0.18	0.64
Quick Ratio	―	0.06	0.05	0.15	0.62
Cash Ratio	―	0.02	<0.01	0.08	0.15
Solvency Ratio	―	-0.08	-0.15	-0.16	-0.50
Operating Cash Flow Ratio	―	-0.06	-0.22	0.03	-0.45
Short-Term Operating Cash Flow Coverage	―	-0.20	-0.83	0.08	-0.78
Net Current Asset Value	C$ ―	C$ -8.22M	C$ -7.62M	C$ -4.26M	C$ -2.70M
Leverage Ratios
Debt-to-Assets Ratio	―	3.63	3.32	5.16	3.09
Debt-to-Equity Ratio	―	-1.08	-1.12	-0.91	-1.22
Debt-to-Capital Ratio	―	13.35	9.28	-10.40	5.51
Long-Term Debt-to-Capital Ratio	―	-116.55	32.37	-3.21	-47.33
Financial Leverage Ratio	―	-0.30	-0.34	-0.18	-0.40
Debt Service Coverage Ratio	―	-0.25	-1.08	-0.75	-1.40
Interest Coverage Ratio	―	-0.64	-1.72	-3.04	-1.77
Debt to Market Cap	―	16.77	11.62	13.70	0.61
Interest Debt Per Share	―	0.27	0.25	0.15	0.14
Net Debt to EBITDA	―	-28.53	-7.76	-6.55	-2.08
Profitability Margins
Gross Profit Margin	―	36.61%	51.87%	40.21%	37.12%
EBIT Margin	―	-281.59%	-945.11%	-257.76%	-252.11%
EBITDA Margin	―	-264.53%	-913.15%	-253.93%	-228.87%
Operating Profit Margin	―	-281.59%	-598.19%	-326.14%	-112.64%
Pretax Profit Margin	―	-706.03%	-1278.19%	-355.09%	-310.30%
Net Profit Margin	―	-712.75%	-1279.85%	-355.09%	-310.30%
Continuous Operations Profit Margin	―	-712.75%	-1279.85%	-355.09%	-310.30%
Net Income Per EBT	―	100.95%	100.13%	100.00%	100.00%
EBT Per EBIT	―	250.73%	213.68%	108.88%	275.48%
Return on Assets (ROA)	―	-34.06%	-59.88%	-106.37%	-191.35%
Return on Equity (ROE)	―	10.14%	20.22%	18.80%	75.60%
Return on Capital Employed (ROCE)	―	471.11%	-260.26%	79.67%	1326.41%
Return on Invested Capital (ROIC)	―	-49.51%	-78.23%	196.86%	-123.66%
Return on Tangible Assets	―	-34.06%	-59.88%	-106.37%	-191.35%
Earnings Yield	―	-157.42%	-211.46%	-291.13%	-37.59%
Efficiency Ratios
Receivables Turnover	―	1.79	1.91	2.67	1.28
Payables Turnover	―	0.04	0.04	0.75	0.88
Inventory Turnover	―	0.00	2.19	2.79	17.39
Fixed Asset Turnover	―	0.00	1.86	1.95	1.92
Asset Turnover	―	0.05	0.05	0.30	0.62
Working Capital Turnover Ratio	―	-0.05	-0.05	-0.18	-29.39
Cash Conversion Cycle	―	-8.16K	-10.05K	-221.14	-106.28
Days of Sales Outstanding	―	204.29	191.13	136.59	285.33
Days of Inventory Outstanding	―	0.00	166.99	130.96	20.99
Days of Payables Outstanding	―	8.36K	10.41K	488.69	412.60
Operating Cycle	―	204.29	358.12	267.55	306.32
Cash Flow Ratios
Operating Cash Flow Per Share	―	>-0.01	-0.01	<0.01	-0.02
Free Cash Flow Per Share	―	>-0.01	-0.01	<0.01	-0.02
CapEx Per Share	―	<0.01	0.00	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	―	1.00	1.00	1.00	1.13
Dividend Paid and CapEx Coverage Ratio	―	-38.79K	0.00	7.44	-4.51
Capital Expenditure Coverage Ratio	―	-38.79K	0.00	7.44	-4.51
Operating Cash Flow Coverage Ratio	―	-0.02	-0.06	0.01	-0.15
Operating Cash Flow to Sales Ratio	―	-1.27	-4.20	0.19	-0.77
Free Cash Flow Yield	―	-28.11%	-69.44%	15.62%	-10.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-0.64	-0.47	-0.34	-2.66
Price-to-Sales (P/S) Ratio	―	4.53	6.05	1.22	8.26
Price-to-Book (P/B) Ratio	―	-0.06	-0.10	-0.06	-2.01
Price-to-Free Cash Flow (P/FCF) Ratio	―	-3.56	-1.44	6.40	-9.46
Price-to-Operating Cash Flow Ratio	―	-3.56	-1.44	6.40	-10.69
Price-to-Earnings Growth (PEG) Ratio	―	0.01	>-0.01	0.02	-0.45
Price-to-Fair Value	―	-0.06	-0.10	-0.06	-2.01
Enterprise Value Multiple	―	-30.24	-8.42	-7.03	-5.69
Enterprise Value	―	7.31M	7.01M	3.64M	7.60M
EV to EBITDA	―	-30.24	-8.42	-7.03	-5.69
EV to Sales	―	79.99	76.91	17.85	13.02
EV to Free Cash Flow	―	-62.86	-18.30	93.68	-14.92
EV to Operating Cash Flow	―	-62.86	-18.30	93.68	-16.86
Tangible Book Value Per Share	―	-0.23	-0.21	-0.15	-0.10
Shareholders’ Equity Per Share	―	-0.23	-0.21	-0.15	-0.10
Tax and Other Ratios
Effective Tax Rate	―	>-0.01	>-0.01	0.00	0.00
Revenue Per Share	―	<0.01	<0.01	<0.01	0.03
Net Income Per Share	―	-0.02	-0.04	-0.03	-0.08
Tax Burden	―	1.01	1.00	1.00	1.00
Interest Burden	―	2.51	1.35	1.38	1.23
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	3.18	6.18	2.28	0.95
Stock-Based Compensation to Revenue	―	0.00	0.00	0.06	-0.03
Income Quality	―	0.18	0.33	-0.05	0.25

Currency in CAD